Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 18, 10:46
415.10
4.8 (1.17%)
VOLUME 29,249
LIVE
NSE
Dec 18, 10:45
415.00
3.8 (0.92%)
VOLUME 218,824
News on Cadila Healthcare
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cadila gets USFDA nod for generic drug to treat Parkinson's disease

5.23 pm | 14 Dec 2017 |  Source: PTI

Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release tablets, used for ...

Zydus receives final approval from USFDA for Pramipexole Dihydrochloride extended-release tablets

12.40 pm | 14 Dec 2017 |  Source: Moneycontrol.com

Zydus Pharmaceuticals, Inc., a wholly owned subsidiary of Cadila Healthcare has received the final approval from the USFDA to market pramipexole Dihyd...

Zydus gets USFDA nod for schizophrenia treatment drug

12.45 pm | 08 Dec 2017 |  Source: PTI

The company has got final approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 25 mg, 50 mg, 100 mg and 20...

Cadila Healthcare shares gain on USFDA approval for Clozapine that treats schizophrenia

11.59 am | 08 Dec 2017 |  Source: Moneycontrol.com

Clozapine tablets will be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad....

Cadila Healthcare gains 1% on USFDA approval for Pregabalin Capsules

1.12 pm | 01 Dec 2017 |  Source: Moneycontrol.com

Zydus Pharmaceuticals Inc, a wholly owned subsidiary of Cadila Healthcare, has received the tentative approval from the USFDA to market Pregabalin Cap...

Zydus receives tentative approval from USFDA for Pregabalin capsules

12.34 pm | 01 Dec 2017 |  Source: Moneycontrol.com

Zydus Pharmaceuticals Inc, a wholly owned subsidiary of Cadila Healthcare, has received the tentative approval from the USFDA to market Pregabalin Cap...

Zydus Cadila gets USFDA nod for blood pressure treatment drug

12.59 pm | 29 Nov 2017 |  Source: PTI

The approval by the US Food and Drug Administration (USFDA) is for multiple Candesartan Cilexetil and hydrochlorothiazide tablets of 16 mg/12.5 mg, 32...

Cadila Healthcare rises 1% on USFDA nod to market drug for high blood pressure

10.55 am | 29 Nov 2017 |  Source: Moneycontrol.com

The drug will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmadabad....

Zydus receives final approval from USFDA for Candesartan Cilexetil and Hydrochlorothiazide tablets

10.46 am | 29 Nov 2017 |  Source: Moneycontrol.com

Zudus Cadila has received the final approval from the USFDA to market Candesartan Cilexetil and hydrochlorothiazide tablets USP in the strengths of 16...

Buy Cadila Healthcare; target of Rs 500: Axis Direct

5.48 pm | 27 Nov 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 500 in its research report dated Novembe...

Zydus receives final approval from USFDA for Topiramate Extended-Release capsules

12.18 pm | 27 Nov 2017 |  Source: Moneycontrol.com

Zydus Cadila has received final approval from the USFDA to market Topiramate extended-release capsules in the strengths of 25 mg, 50 mg and 100 mg....

Zydus gets USFDA nod for seizure, migraine drug

11.46 am | 27 Nov 2017 |  Source: PTI

The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 25 mg, 50 mg and 100 mg, Zydus C...

Zydus' oral anemia developmental candidate, ZYAN1 named as Desidustat by WHO

11.40 am | 20 Nov 2017 |  Source: Moneycontrol.com

Zydus Cadila announced that the WHO INN committee has granted the name Desidustat to its phase II anemia candidate, ZYAN1....

Cadila Healthcare net profit jumps 33% in Q2 on strong US & India formulation sales

12.46 pm | 14 Nov 2017 |  Source: Moneycontrol.com

The company posted Rs 380 crore net profit in the same period of previous year. Revenues jumped 37.4 percent to Rs 3234 crore compared to Rs 2353 cror...

News highlights: Amit Shah confident of BJP winning 150 seats in Gujarat Assembly election

7.11 am | 14 Nov 2017 |  Source: Moneycontrol.com

Here’s wishing all our readers a Happy Children’s Day. This blog will keep track of key global and local developments impacting business and marke...

Zydus gets regulatory nod to market Lipaglyn in Mexico

2.08 pm | 10 Nov 2017 |  Source: PTI

The company has been granted marketing approval from the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary...

Buy Cadila Healthcare, Ashok Leyland, Hindustan Zinc; sell Equitas Holdings, ITC: Sudarshan Sukhani 

9.44 am | 07 Nov 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Cadila Healthcare, Ashok Leyland and Hindustan Zinc and can sell Equitas Holdings...

Buy Cadila Healthcare; target of Rs 506: Geojit Research

4.18 pm | 03 Oct 2017 |  Source: Moneycontrol.com

Geojit Research is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 506 in its research report dated Sep...

Buy Cadila Healthcare; target of Rs 580: Edelweiss

3.23 pm | 08 Sep 2017 |  Source: Moneycontrol.com

Edelweiss is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 580 in its research report dated 06 Septem...

1 2 3 4 5
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.